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Abstract
Background: Rheumatic mitral stenosis (MS) is still a common disease in developing
countries with high morbidity and mortality rates. The purpose of the study was to evaluate
arterial stiffness in severe MS before and after percutaneous mitral balloon valvuloplasty
(PMBV).
Methods: Thirty patients with MS in sinus rhythm requiring PMBV and 20 age-gender
matched healthy volunteers. The analyze of pulse wave velocities (PWV) were performed using
of the carotid artery at the femoral by PWV technique on patients at baseline and a week after
PMBV.
Results: The values of PWV were significantly decreased after successful PMBW in MS
patients. Mitral mean gradients and systolic pulmonary artery pressures (sPAP) both on
echocardiography and catheterization also had a significant decrease after PMBW. The mitral
valve areas were significantly increased after PMBW. There was a highly significant negative
correlation between mitral valve areas and PWV values. A highly significant positive
correlation was seen between mitral mean gradient on catheterization and PWV (r = 0.830,
p < 0.001). There was also a significant correlation between sPAP on catheterization and
PWV values (r = 0.639, p < 0.001). Echocardiographic mitral mean gradients and PWV
were highly positive correlated with each other (r = 0.841, p < 0.001). The sPAP on
echocardiography had also a highly positive correlation with PWV (r = 0.681, p < 0.001).
Conclusions: Mitral stenosis is a cause of impaired arterial stiffness and after the enlargened
mitral valve area arterial stiffness improved in patients with MS. (Cardiol J 2012; 19, 6: 586–590)
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Introduction
Several studies had shown an association be-
tween increased arterial stiffness and aging [1],
diabetes mellitus [2], hypercholesterolemia [3], hy-
pertension [4], smoking [5], congestive heart fail-
ure [6] and chronic kidney disease [7]. Pulse wave
velocity (PWV) is used to measure arterial elastic-
ity and stiffness and is related to the elastic pro-
perties of the vascular wall. Carotid-femoral PWV is
considered the gold-standard measurement of cen-
tral arterial stiffness [8].
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Rheumatic mitral stenosis (MS) is still a com-
mon disease in developing countries with high
morbidity and mortality rates [9]. The safe and ef-
fective treatment of choice for MS patients with
favorable mitral valve morphology is percutaneous
balloon mitral valvuloplasty (PMBV). Successful
PMBV cause significant improvements in early cli-
nical and hemodynamic properties of patients with
MS. While mitral valve area (MVA) increases, the
left atrial pressure, mean transmitral gradient and
pulmonary artery pressure decrease immediately.
To the best of our knowledge there was no data
about the relationship between MS and arterial stiff-
ness in the literature. In this study, we aimed to
show not only the effect of MS on arterial stiffness
but also the change of arterial stiffness after suc-
cessful PMBV.
Methods
We prospectively screened 30 consecutive pa-
tients with rheumatic MS in sinus rhythm (MS
Group) whom required PMBV and 20 age and sex-
matched healthy volunteers (Healthy Group). Pa-
tients with moderate or severe mitral regurgitation,
any moderate or severe valvular heart disease ex-
cept MS, history of hypertension, coronary artery
disease, hypercholesterolemia, diabetes mellitus,
chronic kidney disease, current smoking, body mass
index higher than 25 were exluded from the study.
All patients and volunteers were informed about the
study, and their written consent forms were ob-
tained. The study was approved by the local ethic
committee, performed in accordance to the Decla-
ration of Helsinki.
Pulse wave velocity
Vascular studies were performed in a quiet,
temperature controlled room with subjects resting
in a supine position at baseline and a week after
PMBV. Systolic and diastolic blood pressures were
measured twice using a semi-automated non-inva-
sive oscillometric sphygmomanometer, following
a 10 min rest period on the dominant arm of sub-
jects. Pulse wave analysis was performed using the
carotid artery at the femoral by PWV machine (Mi-
cro medical Pulse Trace, Rochester, UK) in accor-
dance with the manufacturer’s recommendations
before treadmill exercise testing. PWV was calcu-
lated by measuring the time for the pulse wave to
travel between the carotid and femoral arteries. All
measurements were performed by a single opera-
tor blinded to the nature of each exposure.
PWV was determined by means of a noninva-
sive analysis of the propagation time and distance
of the pulse wave between two acquisition points:
PWV = distance [m]/time [s]. The transducers
were positioned over the carotid and femoral arter-
ies, always on the right side of the body and the sig-
nals were sent to the Complior system (France).
Signal acquisition was performed by the same re-
searcher who was blinded to the patient’s condition
position before and after exertion on a stationary
bike, with 15 sequential pulse waves preferentially
recorded. The individual returned to the evaluation
bed for the acquisition of the data as soon as the
predicted heart rate was reached or other exercise
interruption criteria were fulfilled.
Echocardiography
The echocardiographies were carried out by
a cardiology specialist in the echocardiography la-
boratory in our cardiology department at baseline
and a week after PMBV. The echocardiography was
performed by Vivid 7 instruments (GE Medical Sys-
tems, Milwaukee, WI, USA), with a 2.5-MHz trans-
ducer and harmonic imaging. According to the re-
commendations of the American Society of Echo-
cardiography [10], all echocardiographic examina-
tions were performed with the patient lying in the
left lateral decubitus position, and 2-dimensional
images were recorded and measured at the apical
4-chambers, 2-chambers, parasternal long- and
short-axis views. Mitral valve area was calculated
by planimetric method. Diastolic transmitral gra-
dients were measured by continuous-wave Doppler
echocardiography. Systolic pulmonary artery pres-
sure (sPAP) was measured with continuous wave
Doppler. Tricuspid regurgitation velocity (V) re-
corded from any view and used to determine sPAP
(sPAP = 4V2 + right atrial pressure). Right atrial
pressure was calculated using the caval respirato-
ry index as described by Kircher et al. [11].
Catheterization
Cardiac catheterization was performed with
Philips Integris 5000 equipment (Philips Medical
Systems, Best, Netherlands). sPAPs and mitral gra-
dients were also measured with cardiac catheteri-
zation. PMBVs were performed using the Inoue
balloon technique.
Statistical analysis
Categorical variables were presented as fre-
quencies and percentages and were compared with
the c2 test. Continuous variables were expressed
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as means and SD. A value of p < 0.05 was consi-
dered to be significant. To compare the measure-
ments before and after PMBV, student paired t test
was used. Correlation analyses were performed
using the Pearson coefficient of correlation. The
SPSS 15.0 software was used for basic statistical
analysis (Version 15, SPSS Inc., Chicago, IL, USA).
Results
The baseline clinical and demographic proper-
ties of all study subjects were seen in Table 1. There
were no significant differences between the MS
group and Healthy Group with respect to age, sex,
serum creatinine, systolic and diastolic blood pressure
(p > 0.05). The baseline heart rate of MS patients
were higher than healthy volunteers (Table 1). All
patients with MS had successful PMBV without any
complication.
No significant differences was found between
heart rate at PWV measure before PMBV and after
PMBV (70 ± 6 and 69 ± 5, p = 0.4, respectively).
The values of PWV were significantly de-
creased after successful PMBW. Both mitral mean
gradient and sPAP on echocardiography and cathe-
terization also had a significant decrease after suc-
cessful PMBW. The MVA that measured with plan-
nimetric method on echocardiography had a signi-
ficant increase after successful PMBW (Table 2).
There was a highly significant negative corre-
lation between MVA and PWV values (Fig. 1).
A highly significant positive correlation was seen
between mitral mean gradient on catheterization
and PWV (r = 0.830, p < 0.001). There was also
a significant correlation between sPAP on cathe-
terization and PWV values (r = 0.639, p < 0.001).
Echocardiographic mitral mean gradient and
PWV was highly positive correlated with each oth-
er (r = 0.841, p < 0.001). The sPAP on echocar-
diography had also a highly positive correlation with
PWV (r = 0.681, p < 0.001).
Discussion
This study demonstrated that arterial stiffness
as measured by PWV improves after successful
PMBV. Furthermore, the greater the improvement
in MVA then the greater the improvement in arte-
Table 2. Echocardiographic, catheterization and pulse wave velocities data for all study patients before
and after percutaneous mitral balloon valvuloplasty (PMBV).
Before PMBV After PMBV P
Pulse wave velocity [m/s] 10.5 ± 1.6 5.9 ± 1 0 < 0.001
Echocardiographic data:
Mitral valve area [cm2] 1.0 ± 0.1 2.0 ± 0.1 < 0.001
Mean gradient [mm Hg] 15 ± 3 4 ± 0.9 < 0.001
Systolic PAP [mm Hg] 57 ± 15 35 ± 8 < 0.001
Catheterization data:
Mean gradient [mm Hg] 18 ± 4 4 ± 1 < 0.001
Systolic PAP [mm Hg] 54 ± 18 33 ± 10 < 0.001
Data expressed as mean ± SD. P < 0.05 was accepted as a statistically significant; PAP — pulmonary artery pressure
Table 1. Clinical characteristics of study patients.
Variables Mitral stenosis group (n = 30) Healthy group (n = 20) P
Age [years] 40 ± 9 40 ± 6 0.9
Female [%] 53 60 0.4
Creatinine [mg/dL] 0.95 ± 0.16 0.92 ± 0.14 0.5
NYHA functional class 2.1 ± 0.5 –
Systolic blood pressure [mm Hg] 120 ± 14 121 ± 11 0.9
Diastolic blood pressure [mm Hg] 70 ± 9 67 ± 7 0.3
Heart rate [bpm] 89 ± 11 72 ± 07 < 0.001
Data expressed as mean± SD or percentage. P < 0.05 was accepted as a statistically significant. Variables were recorded before the procedure.
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rial stiffness (as measured by PWV). This is the first
study demonstrating the worsened arterial stiffness
by high PVW levels in MS and the improved arteri-
al stiffness after mitral balloon valvuloplasty. The
highly significant positive correlation between PWV
and MVA were also firstly showed in this study. We
found that different degrees of MVA worsened ar-
terial stiffness measured by PWV according to se-
verity of MVA. With our findings it can be said that
the decrease of MVA have directly negative effect
on arterial stiffness.
MS is an obstruction to left ventricular inflow
at the level of the mitral valve as a result of a struc-
tural abnormality of the mitral valve apparatus,
which prevents proper opening during diastolic fill-
ing of the left ventricle [12]. The major cause of MS
is rheumatic fever [13]. Rheumatic MS occurs as
a late sequela of rheumatic fever and is still an im-
portant condition in developing countries. PMBV
is a preferred treatment for symptomatic patients
and favorable anatomical findings with moderate or
severe MS without left atrial thrombus and signifi-
cant mitral regurgitation [12]. It has many benefi-
cial effects at early and late period after successful
balloon valvuloplasty.
The increase in left atrial pressure and trans-
mitral flow and the decrease in the diastolic filling
period are major causes of symptoms in MS. The
low cardiac output and increased pulmonary arteri-
olar resistance result functional and structural
changes such as alveolar basement membrane
thickening, adaptation of neuroreceptors, increased
lymphatic drainage, and increased transpulmonary
endothelin spillover rate in patients with severe MS
[14–16]. MS is a progressive and lifelong disease.
We hypothesize that it may also cause worsening
in stiffness of peripheral arteries. PMBV, which is
the treatment of choice in patients with MS with
favorable mitral valve morphology, is unique in that
it provides dramatic hemodynamic and sympto-
matic relief as soon as it is carried out with success.
Due to these sudden changes in hemodynamic and
metabolic parameters in MS after PMBV, recent-
ly, it seemed to be highly attractive to investigate
some characteristics of MS before and after the pro-
cedure by many clinicians.
Arterial stiffness is an important predictor to
the development of cardiovascular disease. There
are studies which showed acute change of arterial
stiffness in some conditions [17–21]. It was shown
that heart failure patients with normal ejection frac-
tion had higher PWV values than healthy subjects
and reduced aortic compliance might be a major risk
factor for heart failure with normal ejection fraction
[22]. Another study showed lower PWV values were
related with less short-term cardiovascular events
in acute heart failure patients [23]. Radaelli et al.
[24] demonstrated the correlation between im-
paried baroreflex sensitivity and increased PWV
values in chronic heart failure and coronary artery
disease patients. It was known that patients with
MS had increased sempatic activity and impaired
baroreflex sensitivity [25]. In some studies, it was
found that PMBV improves the baroreflex sensitiv-
ity and sempatic activity in MS patients [25, 26]. In
light of this data we thought that with respect to
patients with MS have impaired baroreflex sensi-
tivity and sempatic activity, so they might have re-
duced aortic compliance. In our study, we have
found higher PWV values in MS patients than
healthy controls and showed increased arterial stiff-
ness in MS and improvement of arterial stiffness
after successful treatment of MS with PMBV. The
MS should be treated not only avoid pulmonary ede-
ma but also the negative effect of increased arterial
stiffness which is a strong predictor of future cardio-
vascular events and all-cause mortality [27].
Conclusions
This study demonstrated that MS is a cause of
worsened arterial stiffness and after the enlargened
MVA, arterial stiffness improved in patients with MS.
Conflict of interest: none declared
Figure 1. The correlation analysis of mitral valve area
(MVA) and pulse wave velocity (PWV) values.
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